Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06177535 · ClinicalTrials.gov registry record · NA

A Study of Oral Kavalactones Effect on Nurses

A NA study of Stress, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06177535 is a NA study of Stress that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 200 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06177535, a NA study of Stress, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This research study is being done to assess the impact of taking Kava extract (Piper methysticum), a dietary supplement on cortisol in a healthy nursing population.

Conditions Studied

Interventions

  • DRUG Placebo
  • DIETARY_SUPPLEMENT Kavalactones

Study Locations (1)

Minnesota

  • Mayo Clinic Minnesota - Rochester

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-08-05
Est. Completion 2026-06-30
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06177535

The ClinicalTrials.gov registry entry for NCT06177535 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 785-participant average among 152 other Stress trials with a reported enrollment target (75% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stress appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06177535 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06177535 about?

NCT06177535 is a clinical study titled "A Study of Oral Kavalactones Effect on Nurses". This research study is being done to assess the impact of taking Kava extract (Piper methysticum), a dietary supplement on cortisol in a healthy nursing population.

What is the current status of trial NCT06177535?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-08-05. Estimated completion is 2026-06-30.

What conditions does trial NCT06177535 study?

This clinical trial studies the following conditions: Stress.

What interventions are being tested in trial NCT06177535?

The interventions under investigation include: Placebo (DRUG), Kavalactones (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06177535?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06177535 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.